CPD Events
Assessing; monitoring and supporting adherence in HTE patients: What to consider?
23 Nov 2022
About the event
This session will be the fifth in a series of short; virtual scientific webinars addressing specific questions about the treatment of heavily treatment experienced (HTE) patients with multidrug resistance (MDR). Despite a decline in prevalence and coverage over the years; MDR HIV is still an extremely relevant issue for HIV patients and clinicians alike. HTE patients with limited options remaining represent a critical area of unmet need; and must remain the subject of ongoing research; discussion and collaboration in the field of HIV. ViiV Healthcare invites you to join a series of engaging webinars led by global and regional experts in virology and the clinical management of MDR HIV patients. Each webinar will present a unique opportunity to explore a key question related to the HTE HIV population in Europe. There will be a focus on clinical case discussions to target understanding of treatment decisions and pathways for complex patients in clinical practice.
Send an enquiry
ViiV Healthcare
We are ViiV Healthcare: a global specialist HIV company, 100% focused on researching and delivering new medicines and improving access to care for people living with HIV. Our global headquarters are in Brentford, London UK; with our US headquarters in Research Triangle Park, North Carolina.
Want to learn more?
Similar CPD Events
Healthcare & Medical
2024 and Beyond: From Congress to Clinical Practic...
ViiV Healthcare
This face-to-face; interactive and discussion-based meeting will be an opportunity to review scienti...
Lisbon,
21 Feb 2025
Healthcare & Medical
Best Practices and Challenges in Real-World Data:...
ViiV Healthcare
This in-person interactive course is ideal for the future generation of HIV specialists who wish to...
Vienna ,
20 Feb 2025